Catalyst Event
Hims & Hers Health Inc (HIMS) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
5/11/2026, 12:00:00 AM
First quarter 2026 financial results and conference call on May 11, 2026, with high importance estimated due to potential market impact of earnings guidance, scheduled.
Korean Translation
2026년 5월 11일 2026년 1분기 실적 발표 및 컨퍼런스콜이 실적 가이던스의 시장 영향력을 고려하여 중요도가 높게 예상되며 예정됨.
Related Recent Events
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 fiscal 2027 earnings release is scheduled for May 20, 2026. Low importance assigned as the announcement of an earnings date typically results in ~1% price impact, scheduled.
5/20/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
First quarter 2026 financial results on May 7, 2026, to be released after market close; significant price impact expected based on recent growth trends scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is expected to announce its Q1 2026 financial results scheduled. Scheduled earnings releases are key volatility events with an estimated 5% impact.
5/7/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
First quarter 2026 financial results and business update scheduled for May 5, 2026; high impact from potential 10% price volatility expected.
5/5/2026, 12:00:00 AM
BioNTech SE (BNTX) · Earnings Release
BioNTech will report first-quarter 2026 financial results and provide a corporate update on 2026-05-05; given the sharp March 2026 volatility after guidance and leadership news, this update is likely to be closely watched and could move shares materially, expected.
5/5/2026, 12:00:00 AM
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
Recursion is scheduled to report Q1 2026 financial results on May 4, 2026; analysts forecast an EPS of approximately -$0.27 and revenue of $17.46 million, forecasted. Medium importance is estimated as earnings reports typically drive significant price movement.
5/4/2026, 12:00:00 AM